The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Autologous platelet‐rich fibrin matrix as cell therapy in the healing of chronic lower‐extremity ulcers
Open accessAbstract
A novel autologous platelet‐rich fibrin matrix membrane (PRFM) was assessed for the ability to facilitate healing in patients with chronic lower‐extremity ulcers. Preliminary data are presented from a prospective trial (n=21). Twelve patients were identified with 17 venous leg ulcers (VLU) and nine bearing 13 nonvenous lower‐extremity ulcers. Before enrollment, the patients were evaluated for vascular status and received appropriate surgical intervention to optimize arterial and venous circulatory status. None of the ulcers had responded to a variety of standard treatments from 4 months to 53 years. Initial ulcer size ranged from 0.7 to 65 cm 2 (mean, 11.2 cm 2). Each PRFM‐treated patient received up to three applications of either a 35 or 50 mm fenestrated membrane, depending on initial ulcer size. The primary endpoints were percent and rate of complete closure as measured by digital photography, computerized planimetery, and clinical examination. Patients were followed weekly for 12 weeks with a follow‐up visit at 16 weeks. At each 4‐week interval, the extent of healing was assessed, and those patients with >50% reduction in wound area were allowed to continue to complete closure. Patients with <50% closure received repeated applications. Complete closure was achieved in 66.7% of the VLU patients (64.7% of treated ulcers) in 7.1 weeks (median, 6 weeks) with an average of two applications per patient. Forty‐four percent complete closure was seen with non‐VLU patients (31% of treated ulcers). From the results of this small‐scale pilot study, PRFM shows significant potential for closing of chronic leg ulcers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Bergan, J. J., Schmid-Schönbein, G. W., Smith, P. D. C., Nicolaides, A. N., Boisseau, M. R., & Eklof, B. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055289 · Cited by 933
Cited by
Advances in surgical applications of growth factors for wound healing
Yamakawa, S., & Hayashida, K. (2019) · Burns & Trauma · doi:10.1186/s41038-019-0148-1 · Cited by 347
Biology of platelet-rich plasma and its clinical application in cartilage repair
Xie, X., Zhang, C., & Tuan, R. S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4493 · Cited by 318
Táborská, J., Blanquer, A., Brynda, E., Filová, E., Stiborová, L., Jenčová, V., Havlíčková, K., Riedelová, Z., & Riedel, T. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s393890 · Cited by 21
Metadata
- Authors
- O'Connell, S. M., Impeduglia, T., Hessler, K., Wang, X., Carroll, R. J., & Dardik, H.
- Venue
- Wound Repair and Regeneration
- Publisher
- Wiley
- Published
- 2008-10-27
- Volume
- 16
- Issue
- 6
- Pages
- 749-756
- ISSN
- 1067-1927 (ISSN-L)
- 1524-475X
- OpenAlex
- W2113991983
- Cited by
- 164
- References
- 2
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autologous platelet‐rich fibrin matrix as cell therapy in the healing of chronic lower‐extremity ulcers. https://app.cochat.ai/papers/10.1111/j.1524-475x.2008.00426.x
- The paper
- O'Connell, S. M., Impeduglia, T., Hessler, K., Wang, X., Carroll, R. J., & Dardik, H. (2008). Autologous platelet‐rich fibrin matrix as cell therapy in the healing of chronic lower‐extremity ulcers. Wound Repair and Regeneration. https://doi.org/10.1111/j.1524-475x.2008.00426.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.